한글목차

전 세계 급성 호흡곤란 증후군(ARDS) 치료 시장 규모는 2024-2029년 12억 9,540만 달러에 달할 것으로 예상되며, 예측 기간 동안 6.9%의 CAGR로 성장할 것으로 예상됩니다.

급성 호흡곤란 증후군(ARDS) 치료 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 포함한 벤더 분석 등의 정보를 전해드립니다.

본 보고서는 현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 폐 보호 환기 전략에 대한 관심 증가, 정밀 의료 및 바이오마커 연구의 발전, ECMO 치료의 사용 증가 등이 시장을 주도하고 있습니다.

이 보고서는 향후 몇 년간 급성 호흡곤란 증후군(ARDS) 치료 시장의 성장을 견인할 주요 요인 중 하나로 ARDS에 대한 면역조절요법에 대한 관심의 증가를 꼽았습니다. 또한, ARDS 치료제의 약물 재창출 전략의 부상과 ARDS에 대한 다제 병용요법에 대한 인식이 높아지는 것도 시장의 큰 수요로 이어질 것으로 보입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 Technavio 분석

• 가격 민감도·수명주기·고객 구입 바스켓·채용률·구입 기준 분석
• 인풋의 중요성과 차별화 요인
• 디스럽션 요인
• 성장 촉진요인과 과제의 영향

제3장 시장 상황

• 시장 생태계
• 시장의 특징
• 밸류체인 분석

제4장 시장 규모

• 시장 정의
• 시장 부문 분석
• 시장 규모(2024년)
• 시장 전망(2024-2029년)

제5장 시장 규모 실적

• 급성 호흡곤란 증후군(ARDS) 치료 세계 시장(2019-2023년)
• 유통 채널별 부문 분석(2019-2023년)
• 투여 경로별 부문 분석(2019-2023년)
• 지역별 부문 분석(2019-2023년)
• 국가별 부문 분석(2019-2023년)

제6장 정성 분석

• AI의 영향 : 급성 호흡곤란 증후군(ARDS) 치료 세계 시장

제7장 Five Forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 참여업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 상황

제8장 시장 세분화 : 유통 채널별

• 시장 부문
• 비교 : 유통 채널별
• 원내 약국 : 시장 규모와 예측(2024-2029년)
• 소매 약국 : 시장 규모와 예측(2024-2029년)
• 온라인 약국 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 유통 채널별

제9장 시장 세분화 : 투여 경로별

• 시장 부문
• 비교 : 투여 경로별
• 경구 : 시장 규모와 예측(2024-2029년)
• 주사 : 시장 규모와 예측(2024-2029년)
• 흡입 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 투여 경로별

제10장 고객 상황

• 고객 상황 개요

제11장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2024-2029년)
• 유럽 : 시장 규모와 예측(2024-2029년)
• 아시아 : 시장 규모와 예측(2024-2029년)
• 세계 기타 지역 : 시장 규모와 예측(2024-2029년)
• 미국 : 시장 규모와 예측(2024-2029년)
• 캐나다 : 시장 규모와 예측(2024-2029년)
• 독일 : 시장 규모와 예측(2024-2029년)
• 중국 : 시장 규모와 예측(2024-2029년)
• 프랑스 : 시장 규모와 예측(2024-2029년)
• 일본 : 시장 규모와 예측(2024-2029년)
• 영국 : 시장 규모와 예측(2024-2029년)
• 이탈리아 : 시장 규모와 예측(2024-2029년)
• 인도 : 시장 규모와 예측(2024-2029년)
• 한국 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 지역 상황별

제12장 촉진요인, 과제, 기회, 억제요인

• 시장 성장 촉진요인
• 시장 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회·억제요인

제13장 경쟁 구도

• 개요
• 경쟁 구도
• 디스럽션 상황
• 업계 리스크

제14장 경쟁 분석

• 기업 개요
• 기업 순위 지수
• 기업의 시장 포지셔닝
• APEPTICO Forschung and Entwicklung GmbH
• Athersys Inc.
• Dragerwerk AG and Co. KGaA
• Edesa Biotech Inc.
• Fisher and Paykel Healthcare Corp. Ltd.
• GE Healthcare Technologies Inc.
• Getinge AB
• Hamilton Medical AG
• Koninklijke Philips NV
• LivaNova PLC
• Medtronic Plc
• Nihon Kohden Corp.
• ResMed Inc.
• Smiths Group Plc
• Vyaire Medical Inc.

제15장 부록

영문목차

The acute respiratory distress syndrome treatment market is forecasted to grow by USD 1295.4 mn during 2024-2029, accelerating at a CAGR of 6.9% during the forecast period. The report on the acute respiratory distress syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing focus on lung-protective ventilation strategies, advances in precision medicine and biomarker research, and increasing utilization of ecmo therapy.

Technavio's acute respiratory distress syndrome treatment market is segmented as below:

By Distribution Channel

• Hospitals pharmacies
• Retail pharmacies
• Online pharmacies

By Route Of Administration

• Oral
• Injection
• Inhalation

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing interest in immunomodulatory therapies for ards as one of the prime reasons driving the acute respiratory distress syndrome treatment market growth during the next few years. Also, emergence of ards drug repurposing strategies and increasing recognition of multimodal supportive care for ards will lead to sizable demand in the market.

The report on the acute respiratory distress syndrome treatment market covers the following areas:

• Acute Respiratory Distress Syndrome Treatment Market sizing
• Acute Respiratory Distress Syndrome Treatment Market forecast
• Acute Respiratory Distress Syndrome Treatment Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading acute respiratory distress syndrome treatment market vendors that include Air Liquide SA, APEPTICO Forschung and Entwicklung GmbH, Athersys Inc., Boston Scientific Corp., Dragerwerk AG and Co. KGaA, Edesa Biotech Inc., Fisher and Paykel Healthcare Corp. Ltd., GE Healthcare Technologies Inc., Getinge AB, Hamilton Medical AG, Koninklijke Philips NV, LivaNova PLC, Medtronic Plc, Nihon Kohden Corp., ResMed Inc., SCHILLER AG, Sleepnet Corp., Smiths Group Plc, Stryker Corp., and Vyaire Medical Inc.. Also, the acute respiratory distress syndrome treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Market Segmentation by Route of Administration
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Acute Respiratory Distress Syndrome Treatment Market 2019 - 2023
  • Historic Market Size - Data Table on Global Acute Respiratory Distress Syndrome Treatment Market 2019 - 2023 ($ million)
• 5.2 Distribution Channel segment analysis 2019 - 2023
  • Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
• 5.3 Route of Administration segment analysis 2019 - 2023
  • Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
• 5.4 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.5 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI in the Global Acute Respiratory Distress Syndrome Treatment Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Distribution Channel

• 8.1 Market segments
  • Chart on Distribution Channel - Market share 2024-2029 (%)
  • Data Table on Distribution Channel - Market share 2024-2029 (%)
• 8.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
• 8.3 Hospitals pharmacies - Market size and forecast 2024-2029
  • Chart on Hospitals pharmacies - Market size and forecast 2024-2029 ($ million)
  • Data Table on Hospitals pharmacies - Market size and forecast 2024-2029 ($ million)
  • Chart on Hospitals pharmacies - Year-over-year growth 2024-2029 (%)
  • Data Table on Hospitals pharmacies - Year-over-year growth 2024-2029 (%)
• 8.4 Retail pharmacies - Market size and forecast 2024-2029
  • Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
  • Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
  • Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
  • Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
• 8.5 Online pharmacies - Market size and forecast 2024-2029
  • Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
  • Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
  • Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
  • Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
• 8.6 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)

9 Market Segmentation by Route of Administration

• 9.1 Market segments
  • Chart on Route of Administration - Market share 2024-2029 (%)
  • Data Table on Route of Administration - Market share 2024-2029 (%)
• 9.2 Comparison by Route of Administration
  • Chart on Comparison by Route of Administration
  • Data Table on Comparison by Route of Administration
• 9.3 Oral - Market size and forecast 2024-2029
  • Chart on Oral - Market size and forecast 2024-2029 ($ million)
  • Data Table on Oral - Market size and forecast 2024-2029 ($ million)
  • Chart on Oral - Year-over-year growth 2024-2029 (%)
  • Data Table on Oral - Year-over-year growth 2024-2029 (%)
• 9.4 Injection - Market size and forecast 2024-2029
  • Chart on Injection - Market size and forecast 2024-2029 ($ million)
  • Data Table on Injection - Market size and forecast 2024-2029 ($ million)
  • Chart on Injection - Year-over-year growth 2024-2029 (%)
  • Data Table on Injection - Year-over-year growth 2024-2029 (%)
• 9.5 Inhalation - Market size and forecast 2024-2029
  • Chart on Inhalation - Market size and forecast 2024-2029 ($ million)
  • Data Table on Inhalation - Market size and forecast 2024-2029 ($ million)
  • Chart on Inhalation - Year-over-year growth 2024-2029 (%)
  • Data Table on Inhalation - Year-over-year growth 2024-2029 (%)
• 9.6 Market opportunity by Route of Administration
  • Market opportunity by Route of Administration ($ million)
  • Data Table on Market opportunity by Route of Administration ($ million)

10 Customer Landscape

• 10.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

• 11.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 11.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 11.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 11.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 11.5 Asia - Market size and forecast 2024-2029
  • Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Data Table on Asia - Year-over-year growth 2024-2029 (%)
• 11.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• 11.7 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ million)
  • Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 11.8 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 11.9 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 11.10 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ million)
  • Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 11.11 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ million)
  • Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 11.12 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 11.13 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 11.14 Italy - Market size and forecast 2024-2029
  • Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Data Table on Italy - Year-over-year growth 2024-2029 (%)
• 11.15 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ million)
  • Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 11.16 South Korea - Market size and forecast 2024-2029
  • Chart on South Korea - Market size and forecast 2024-2029 ($ million)
  • Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
  • Chart on South Korea - Year-over-year growth 2024-2029 (%)
  • Data Table on South Korea - Year-over-year growth 2024-2029 (%)
• 11.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

• 12.1 Market drivers
• 12.2 Market challenges
• 12.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 12.4 Market opportunities/restraints

13 Competitive Landscape

• 13.1 Overview
• 13.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 13.3 Landscape disruption
  • Overview on factors of disruption
• 13.4 Industry risks
  • Impact of key risks on business

14 Competitive Analysis

• 14.1 Companies profiled
  • Companies covered
• 14.2 Company ranking index
  • Company ranking index
• 14.3 Market positioning of companies
  • Matrix on companies position and classification
• 14.4 APEPTICO Forschung and Entwicklung GmbH
  • APEPTICO Forschung and Entwicklung GmbH - Overview
  • APEPTICO Forschung and Entwicklung GmbH - Product / Service
  • APEPTICO Forschung and Entwicklung GmbH - Key offerings
  • SWOT
• 14.5 Athersys Inc.
  • Athersys Inc. - Overview
  • Athersys Inc. - Product / Service
  • Athersys Inc. - Key offerings
  • SWOT
• 14.6 Dragerwerk AG and Co. KGaA
  • Dragerwerk AG and Co. KGaA - Overview
  • Dragerwerk AG and Co. KGaA - Business segments
  • Dragerwerk AG and Co. KGaA - Key news
  • Dragerwerk AG and Co. KGaA - Key offerings
  • Dragerwerk AG and Co. KGaA - Segment focus
  • SWOT
• 14.7 Edesa Biotech Inc.
  • Edesa Biotech Inc. - Overview
  • Edesa Biotech Inc. - Product / Service
  • Edesa Biotech Inc. - Key offerings
  • SWOT
• 14.8 Fisher and Paykel Healthcare Corp. Ltd.
  • Fisher and Paykel Healthcare Corp. Ltd. - Overview
  • Fisher and Paykel Healthcare Corp. Ltd. - Product / Service
  • Fisher and Paykel Healthcare Corp. Ltd. - Key news
  • Fisher and Paykel Healthcare Corp. Ltd. - Key offerings
  • SWOT
• 14.9 GE Healthcare Technologies Inc.
  • GE Healthcare Technologies Inc. - Overview
  • GE Healthcare Technologies Inc. - Business segments
  • GE Healthcare Technologies Inc. - Key news
  • GE Healthcare Technologies Inc. - Key offerings
  • GE Healthcare Technologies Inc. - Segment focus
  • SWOT
• 14.10 Getinge AB
  • Getinge AB - Overview
  • Getinge AB - Business segments
  • Getinge AB - Key news
  • Getinge AB - Key offerings
  • Getinge AB - Segment focus
  • SWOT
• 14.11 Hamilton Medical AG
  • Hamilton Medical AG - Overview
  • Hamilton Medical AG - Product / Service
  • Hamilton Medical AG - Key offerings
  • SWOT
• 14.12 Koninklijke Philips NV
  • Koninklijke Philips NV - Overview
  • Koninklijke Philips NV - Business segments
  • Koninklijke Philips NV - Key news
  • Koninklijke Philips NV - Key offerings
  • Koninklijke Philips NV - Segment focus
  • SWOT
• 14.13 LivaNova PLC
  • LivaNova PLC - Overview
  • LivaNova PLC - Business segments
  • LivaNova PLC - Key news
  • LivaNova PLC - Key offerings
  • LivaNova PLC - Segment focus
  • SWOT
• 14.14 Medtronic Plc
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key news
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Segment focus
  • SWOT
• 14.15 Nihon Kohden Corp.
  • Nihon Kohden Corp. - Overview
  • Nihon Kohden Corp. - Business segments
  • Nihon Kohden Corp. - Key news
  • Nihon Kohden Corp. - Key offerings
  • Nihon Kohden Corp. - Segment focus
  • SWOT
• 14.16 ResMed Inc.
  • ResMed Inc. - Overview
  • ResMed Inc. - Business segments
  • ResMed Inc. - Key news
  • ResMed Inc. - Key offerings
  • ResMed Inc. - Segment focus
  • SWOT
• 14.17 Smiths Group Plc
  • Smiths Group Plc - Overview
  • Smiths Group Plc - Business segments
  • Smiths Group Plc - Key news
  • Smiths Group Plc - Key offerings
  • Smiths Group Plc - Segment focus
  • SWOT
• 14.18 Vyaire Medical Inc.
  • Vyaire Medical Inc. - Overview
  • Vyaire Medical Inc. - Product / Service
  • Vyaire Medical Inc. - Key offerings
  • SWOT

15 Appendix

• 15.1 Scope of the report
• 15.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 15.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 15.4 Research methodology
  • Research methodology
• 15.5 Data procurement
  • Information sources
• 15.6 Data validation
  • Data validation
• 15.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 15.8 Data synthesis
  • Data synthesis
• 15.9 360 degree market analysis
  • 360 degree market analysis
• 15.10 List of abbreviations
  • List of abbreviations